These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 25325123)

  • 1. Temozolomide: fatal hepatic failure.
    Prescrire Int; 2014 Sep; 23(152):214. PubMed ID: 25325123
    [No Abstract]   [Full Text] [Related]  

  • 2. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
    Neyns B; Hoorens A; Stupp R
    Acta Neurol Belg; 2008 Dec; 108(4):131-4. PubMed ID: 19239041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
    Grieco A; Tafuri MA; Biolato M; Diletto B; Di Napoli N; Balducci N; Vecchio FM; Miele L
    Medicine (Baltimore); 2015 Mar; 94(12):e476. PubMed ID: 25816026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute liver injury induced by levetiracetam and temozolomide co-treatment.
    Khoury T; Chen S; Abu Rmeileh A; Daher S; Yaari S; Benson AA; Cohen J; Mizrahi M
    Dig Liver Dis; 2017 Mar; 49(3):297-300. PubMed ID: 28034663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
    Zamani N; Mohammad Alizadeh A
    Neuro Oncol; 2012 Jul; 14(7):830. PubMed ID: 22544734
    [No Abstract]   [Full Text] [Related]  

  • 6. Temozolomide-induced liver damage. A case report.
    Becker F; Hecht M; Schmidtner J; Semrau S; Fietkau R
    Strahlenther Onkol; 2014 Apr; 190(4):408-10. PubMed ID: 24452817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute temozolomide induced liver injury: mixed type hepatocellular and cholestatic toxicity.
    Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
    Acta Gastroenterol Belg; 2016; 79(2):363-365. PubMed ID: 27821033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histological features of idiosyncratic acute liver injury caused by temozolomide.
    Grant LM; Kleiner DE; Conjeevaram HS; Vuppalanchi R; Lee WM
    Dig Dis Sci; 2013 May; 58(5):1415-21. PubMed ID: 23212393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in the Histopathology of Drug-Induced Liver Injury.
    Kleiner DE
    Surg Pathol Clin; 2018 Jun; 11(2):297-311. PubMed ID: 29751876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temozolomide induced liver injury.
    Dixit S; Hingorani M; Afzal P; Campbell AP
    Acta Neurol Belg; 2011 Sep; 111(3):249-51. PubMed ID: 22141295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glucocorticoids in the treatment of fulminant hepatitis induced by dacarbazine.
    Herishanu Y; Lishner M; Kitay-Cohen Y
    Anticancer Drugs; 2002 Feb; 13(2):177-9. PubMed ID: 11901312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenprocoumon-induced liver failure.
    de Man RA
    Neth J Med; 1993 Aug; 43(1-2):91. PubMed ID: 8232701
    [No Abstract]   [Full Text] [Related]  

  • 13. Rodenticide-induced hepatotoxicity.
    Karanth S; Nayyar V
    J Assoc Physicians India; 2003 Aug; 51():816-7. PubMed ID: 14651148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute temozolomide induced liver injury : Mixed type hepatocellular and cholestatic toxicity.
    Aygun C; Altınok AY; Çakır A; Agan AF; Balaban Y
    Acta Gastroenterol Belg; 2016; 79(4):487-489. PubMed ID: 28209108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aplastic anaemia in patient with glioblastoma multiforme treated with temozolomide.
    Villano JL; Collins CA; Manasanch EE; Ramaprasad C; van Besien K
    Lancet Oncol; 2006 May; 7(5):436-8. PubMed ID: 16648049
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute cholestatic hepatitis due to chlorambucil].
    Pichon N; Debette-Gratien M; Cessot F; Paraf F; Labrousse F; Sautereau D; Pillegand B
    Gastroenterol Clin Biol; 2001 Feb; 25(2):202-3. PubMed ID: 11319447
    [No Abstract]   [Full Text] [Related]  

  • 17. [Radiation and temozolomide therapy].
    Sonoda Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():619-22. PubMed ID: 25831834
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment-related myelodysplastic syndrome after temozolomide use in a child: first report.
    Dufour C; Da Costa L; Auger N; Jullien M; Bhangoo R; Grill J
    J Pediatr Hematol Oncol; 2008 Nov; 30(11):857-9. PubMed ID: 18989164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temozolomide for melanoma: new toxicities and new opportunities.
    Gajewski TF
    J Clin Oncol; 2004 Feb; 22(4):580-1. PubMed ID: 14726506
    [No Abstract]   [Full Text] [Related]  

  • 20. Fatal reactivation of hepatitis B with temozolomide.
    Grewal J; Dellinger CA; Yung WK
    N Engl J Med; 2007 Apr; 356(15):1591-2. PubMed ID: 17429098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.